Clinical trials / Rhode Island
Psychedelic and ketamine trials recruiting in Rhode Island
3 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Rhode Island on 26 Oct 2026. By substance: Ketamine / esketamine 1, MDMA 1, Psilocybin 1. By condition: depression 1, ptsd 1, alcohol use disorder 1.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 3Ketamine / esketamineNCT07227454
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder (AVENUE)
- Conditions:
- Depressive Disorder, Major
- Sponsor:
- Janssen Research & Development, LLC
- Who:
- ages 12 Years to 17 Years, 258 participants planned
- Also in:
- Brazil, Hungary, Italy, Romania, Spain, Taiwan
- Bradley Hospital, East Providence, Rhode Island
Phase 2/3MDMANCT07118839
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder (MAP VETS)
- Conditions:
- Post Traumatic Stress Disorder; Alcohol Use Disorder
- Sponsor:
- VA Office of Research and Development
- Who:
- ages 18 Years and over, 80 participants planned
- Providence VA Medical Center, Providence, RI, Providence, Rhode Island
Phase 1PsilocybinNCT07818564
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
- Conditions:
- Phase I
- Sponsor:
- Brown University
- Who:
- ages 18 Years and over, 24 participants planned, accepts healthy volunteers
- Brown University School of Public Health, Providence, Rhode Island